R Oberneder
Overview
Explore the profile of R Oberneder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wessels F, Kriegmair M, Oehme A, Rassweiler-Seyfried M, Erben P, Oberneder R, et al.
Eur J Surg Oncol
. 2019 Mar;
45(7):1260-1265.
PMID: 30827801
Introduction: Aim of this study was to analyse the perioperative outcome of patients undergoing radical cystectomy under continuous antiplatelet therapy with acetylsalicylic acid. Materials And Methods: Using prospectively maintained databases...
2.
Vogelhuber M, Feyerabend S, Stenzl A, Suedhoff T, Schulze M, Huebner J, et al.
Cancer Microenviron
. 2015 Feb;
8(1):43-4.
PMID: 25651886
No abstract available.
3.
Vogelhuber M, Feyerabend S, Stenzl A, Suedhoff T, Schulze M, Huebner J, et al.
Cancer Microenviron
. 2014 Dec;
8(1):33-41.
PMID: 25503648
Therapeutic options for patients with castration-resistant prostate cancer (CRPC) remain limited. In a multicenter, Phase II study, 65 patients with histologically confirmed CRPC received a biomodulatory regimen during the six-month...
4.
Siebels M, Hegele A, Varga Z, Oberneder R, Doehn C, Heinzer H
Urologe A
. 2011 May;
50(9):1110-7.
PMID: 21559917
Background: Since 2006 in Germany six different target drugs for therapy in metastatic renal cell cancer (mRCC) have been used. Comparative studies for the application with the same indication are...
5.
Siebels M, Rohrmann K, Oberneder R, Stahler M, Haseke N, Beck J, et al.
World J Urol
. 2010 Jun;
29(1):121-6.
PMID: 20512580
Purpose: To evaluate the efficacy and safety of WX-G250, a chimeric monoclonal antibody that binds to carboxy anhydrase IX, combined with low-dose interferon-alpha (LD-IFNα) in patients with progressive metastatic renal...
6.
Siebels M, Staehler M, Hegele A, Varga Z, Oberneder R, Doehn C, et al.
Aktuelle Urol
. 2009 Nov;
41(2):122-30.
PMID: 19937556
Introduction: Until recently, the standard therapy for metastatic renal cell carcinoma (mRCC) in Germany consisted of interleukin-2 (IL-2), interferon-alfa (IFN) as single agents or in combination, with or without chemotherapy....
7.
Atzpodien J, Kirchner H, Jonas U, Bergmann L, Schott H, Heynemann H, et al.
J Clin Oncol
. 2004 Feb;
22(7):1188-94.
PMID: 14981107
Purpose: We conducted a prospectively randomized clinical trial to compare the efficacy of three outpatient therapy regimens in 341 patients with progressive metastatic renal cell carcinoma. Patients And Methods: Patients...
8.
Piltz S, Meimarakis G, Wichmann M, Oberneder R, Jauch K, Furst H
Urologe A
. 2003 Sep;
42(9):1230-7.
PMID: 14504756
Based on a large single-center follow-up database, we evaluated the long-term results after curative resection of pulmonary metastases from renal cancer. During a 20-year period, 105 patients underwent a total...
9.
Schaffer M, Schaffer P, Vogesser M, Ertl-Wagner B, Rauch J, Oberneder R, et al.
Photochem Photobiol Sci
. 2003 Apr;
1(9):686-9.
PMID: 12665306
Background: The effect of ionizing radiation on tumour tissues can be optimised by adding radiosensitising agents to enhance tumour inactivation. Photofrin II has been approved as a photosensitising agent for...
10.
Frimberger D, Kavoussi L, Stoianovici D, Adam C, Zaak D, Corvin S, et al.
Urologe A
. 2002 Nov;
41(5):489-92.
PMID: 12426868
The rapid development of laparoscopy in urology necessitates the training of specialists to guarantee the high standard of patient care. The real-time data communication of medical information between physicians in...